C. Lebrun-Frénay Et Al. , "Teriflunomide and Time to Clinical Multiple Sclerosis in Patients With Radiologically Isolated Syndrome: The TERIS Randomized Clinical Trial," JAMA neurology , vol.80, no.10, pp.1080-1088, 2023
Lebrun-Frénay, C. Et Al. 2023. Teriflunomide and Time to Clinical Multiple Sclerosis in Patients With Radiologically Isolated Syndrome: The TERIS Randomized Clinical Trial. JAMA neurology , vol.80, no.10 , 1080-1088.
Lebrun-Frénay, C., SİVA, A., Sormani, M. P., Landes-Chateau, C., Mondot, L., Bovis, F., ... Vermersch, P.(2023). Teriflunomide and Time to Clinical Multiple Sclerosis in Patients With Radiologically Isolated Syndrome: The TERIS Randomized Clinical Trial. JAMA neurology , vol.80, no.10, 1080-1088.
Lebrun-Frénay, Christine Et Al. "Teriflunomide and Time to Clinical Multiple Sclerosis in Patients With Radiologically Isolated Syndrome: The TERIS Randomized Clinical Trial," JAMA neurology , vol.80, no.10, 1080-1088, 2023
Lebrun-Frénay, Christine Et Al. "Teriflunomide and Time to Clinical Multiple Sclerosis in Patients With Radiologically Isolated Syndrome: The TERIS Randomized Clinical Trial." JAMA neurology , vol.80, no.10, pp.1080-1088, 2023
Lebrun-Frénay, C. Et Al. (2023) . "Teriflunomide and Time to Clinical Multiple Sclerosis in Patients With Radiologically Isolated Syndrome: The TERIS Randomized Clinical Trial." JAMA neurology , vol.80, no.10, pp.1080-1088.
@article{article, author={Christine Lebrun-Frénay Et Al. }, title={Teriflunomide and Time to Clinical Multiple Sclerosis in Patients With Radiologically Isolated Syndrome: The TERIS Randomized Clinical Trial}, journal={JAMA neurology}, year=2023, pages={1080-1088} }